Alessia Franceschini

Alessia Franceschini

Auto-generated profile, based on publicly available information

Alessia Franceschini

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AFAlessia Franceschini
Alessia Franceschini
MCMarina Capece
Marina Capece
PCPaola Chiozzi
Paola Chiozzi
SFSimonetta Falzoni
Simonetta Falzoni
JSJuana M Sanz
Juana M Sanz
Francesco Di VirgilioFrancesco Di Virgilio
Francesco Di Virgilio
The P2X7 receptor (P2X7R) is a known and powerful activator of the NOD‐like receptor (NLR)P3 inflammasome; however, the underlying pathways are poorly understood. Thus, we investigated the molecular mechanisms involved. The effect of P2X7R expression and activation on NLRP3 expression and recruitment was investigated by Western blot, RT‐PCR, coimmunoprecipitation, and confocal microscopy in microglial mouse cell lines selected for reduced P2X7R expression and in primary cells from P2X7R ‐/‐ C57BL/6 mice. We show here that P2X7R activation by ATP (EC 50 = 1 mM) or benzoyl‐ATP (EC 50 = 300 μM) and P2X7R down‐modulation caused a 2‐ to 8‐fold up‐regulation of NLRP3 mRNA in mouse N13 microglial cells. Moreover, NLRP3 mRNA was also up‐regulated in primary microglial and macrophage cells from P2X7R ‐/‐ mice. Confocal microscopy and immunoprecipitation assays showed that P2X7R and NLRP3 closely interacted at discrete subplasmalemmal sites. Finally, P2X7R stimulation caused a transient (3‐4 min) cytoplasmic Ca 2+ increase localized to small (2‐3 μm wide) discrete subplasmalemmal regions. The Ca 2+ increase drove P2X7R recruitment and a 4‐fold increase in P2X7R/NLRP3 association within 1‐2 min. These data show a close P2X7R and NLRP3 interaction and highlight the role of P2X7R in the localized cytoplasmic ion changes responsible for both NLRP3 recruitment and activation.— Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J. M., Sarti, A. C., Bonora, M., Pinton, P., Di Virgilio, F. The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J. 29, 2450‐2461 (2015). www.fasebj.org

26 January 2015 in Oncogene
Verified
Journal Article
Closed access
FAF Amoroso
F Amoroso
MCM Capece
M Capece
ARA Rotondo
A Rotondo
DCDavide Cangelosi
Davide Cangelosi
MFManuela Ferracin
Manuela Ferracin
Adinolfi ElenaAdinolfi Elena
Adinolfi Elena

15 February 2015 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Adinolfi ElenaAdinolfi Elena
Adinolfi Elena
MCMarina Capece
Marina Capece
AFAlessia Franceschini
Alessia Franceschini
SFSimonetta Falzoni
Simonetta Falzoni
Anna Lisa GiulianiAnna Lisa Giuliani
Anna Lisa Giuliani
Francesco Di VirgilioFrancesco Di Virgilio
Francesco Di Virgilio
The ATP receptor P2X7 (P2X7R or P2RX7) has a key role in inflammation and immunity, but its possible roles in cancer are not firmly established. In the present study, we investigated the effect of host genetic deletion of P2X7R in the mouse on the growth of B16 melanoma or CT26 colon carcinoma cells. Tumor size and metastatic dissemination were assessed by in vivo calliper and luciferase luminescence emission measurements along with postmortem examination. In P2X7R-deficient mice, tumor growth and metastatic spreading were accelerated strongly, compared with wild-type (wt) mice. Intratumoral IL-1β and VEGF release were drastically reduced, and inflammatory cell infiltration was abrogated nearly completely. Similarly, tumor growth was also greatly accelerated in wt chimeric mice implanted with P2X7R-deficient bone marrow cells, defining hematopoietic cells as a sufficient site of P2X7R action. Finally, dendritic cells from P2X7R-deficient mice were unresponsive to stimulation with tumor cells, and chemotaxis of P2X7R-less cells was impaired. Overall, our results showed that host P2X7R expression was critical to support an antitumor immune response, and to restrict tumor growth and metastatic diffusion. Cancer Res; 75(4); 635–44. ©2014 AACR.

15 February 2017 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
FLFrancesca Lattanzio
Francesca Lattanzio
SASamir Abu-Rumeileh
Samir Abu-Rumeileh
AFAlessia Franceschini
Alessia Franceschini
HKHideaki Kai
Hideaki Kai
GAGiulia Amore
Giulia Amore
PPPiero Parchi
Piero Parchi
The differential diagnosis of Creutzfeldt-Jakob disease (CJD) from other, sometimes treatable, neurological disorders is challenging, owing to the wide phenotypic heterogeneity of the disease. Real-time quaking-induced prion conversion (RT-QuIC) is a novel ultrasensitive in vitro assay, which, at variance with surrogate neurodegenerative biomarker assays, specifically targets the pathological prion protein (PrPSc). In the studies conducted to date in CJD, cerebrospinal fluid (CSF) RT-QuIC showed good diagnostic sensitivity (82–96%) and virtually full specificity. In the present study, we investigated the diagnostic value of both prion RT-QuIC and surrogate protein markers in a large patient population with suspected CJD and then evaluated the influence on CSF findings of the CJD type, and the associated amyloid-β (Aβ) and tau neuropathology. RT-QuIC showed an overall diagnostic sensitivity of 82.1% and a specificity of 99.4%. However, sensitivity was lower in CJD types linked to abnormal prion protein (PrPSc) type 2 (VV2, MV2K and MM2C) than in typical CJD (MM1). Among surrogate proteins markers (14-3-3, total (t)-tau, and t-tau/phosphorylated (p)-tau ratio) t-tau performed best in terms of both specificity and sensitivity for all sCJD types. Sporadic CJD VV2 and MV2K types demonstrated higher CSF levels of p-tau when compared to other sCJD types and this positively correlated with the amount of tiny tau deposits in brain areas showing spongiform change. CJD patients showed moderately reduced median Aβ42 CSF levels, with 38% of cases having significantly decreased protein levels in the absence of Aβ brain deposits. Our results: (1) support the use of both RT-QuIC and t-tau assays as first line laboratory investigations for the clinical diagnosis of CJD; (2) demonstrate a secondary tauopathy in CJD subtypes VV2 and MV2K, correlating with increased p-tau levels in the CSF and (3) provide novel insight into the issue of the accuracy of CSF p-tau and Aβ42 as markers of brain tauopathy and β-amyloidosis.

11 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AFAlessia Franceschini
Alessia Franceschini
SVSandra Vilotti
Sandra Vilotti
MFMichel D Ferrari
Michel D Ferrari
AMArn M J M Van Den Maagdenberg
Arn M J M Van Den Maagdenberg
ANAndrea Nistri
Andrea Nistri
EFElsa Fabbretti
Elsa Fabbretti
Latent changes in trigeminal ganglion structure and function resembling inflammatory conditions may predispose to acute attacks of migraine pain. Here, we investigated whether, in trigeminal sensory ganglia, cytokines such as TNFα might contribute to a local inflammatory phenotype of a transgenic knock-in (KI) mouse model of familial hemiplegic migraine type-1 (FHM-1). To this end, macrophage occurrence and cytokine expression in trigeminal ganglia were compared between wild type (WT) and R192Q mutant CaV2.1 Ca2+ channel (R192Q KI) mice, a genetic model of FHM-1. Cellular and molecular characterization was performed using a combination of confocal immunohistochemistry and cytokine assays. With respect to WT, R192Q KI trigeminal ganglia were enriched in activated macrophages as suggested by their morphology and immunoreactivity to the markers Iba1, CD11b, and ED1. R192Q KI trigeminal ganglia constitutively expressed higher mRNA levels of IL1β, IL6, IL10 and TNFα cytokines and the MCP-1 chemokine. Consistent with the report that TNFα is a major factor to sensitize trigeminal ganglia, we observed that, following an inflammatory reaction evoked by LPS injection, TNFα expression and macrophage occurrence were significantly higher in R192Q KI ganglia with respect to WT ganglia. Our data suggest that, in KI trigeminal ganglia, the complex cellular and molecular environment could support a new tissue phenotype compatible with a neuroinflammatory profile. We propose that, in FHM patients, this condition might contribute to trigeminal pain pathophysiology through release of soluble mediators, including TNFα, that may modulate the crosstalk between sensory neurons and resident glia, underlying the process of neuronal sensitisation.

2 February 2015 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Adinolfi ElenaAdinolfi Elena
Adinolfi Elena
MCMarina Capece
Marina Capece
FAFrancesca Amoroso
Francesca Amoroso
EMElena De Marchi
Elena De Marchi
AFAlessia Franceschini
Alessia Franceschini
Tumor microenvironment composition strongly conditions cancer growth and progression, acting not only at cancer itself but also modifying its interactions with immune, endothelial and nervous cells. Extracellular ATP and its receptors recently gained increasing attention in the oncological field. ATP accumulates in cancer milieu through spontaneous release, tumor necrosis or chemotherapy exerting a trophic activity on cancer cells, modulating the cross talk among tumor, and surrounding tissues. Accordingly, ATP gated P2X receptors emerged as central players in tumor development, invasion, progression and related symptoms. Indeed, P2X receptors are expressed and are functional not only on tumor cells but also in immune-infiltrate and nearby neurons. In this review, we summarize recent findings on P2X receptors role in tumor cell differentiation, bioenergetics, angiogenesis, metastasis and associated pain, giving an outline of the potential anti-neoplastic activity of receptor agonists and antagonists.